OK, as far as a 'leap of faith' goes - consider this.
There are a plethora of non (or virtually non) income generating stocks on the ASX, many who have been battling away for years since IPO'ing, through various cap raises and with a billion plus SOI (or they have been through one or more consolidations).As far as Hot Copper goes they all have one thing in common. A group of die hard blind faith followers up against an opposite group of die hard shit-canners. I think both groups imagine that they are unique to their stock and that it is different from the rest. Well, they are not - they exist everywhere. Of the blind faith crew (a very few) lucky ones win out in the end, the (vast majority) hang in until the penny drops and most probably attempt to discover the next potential 'el Dorado'. In the middle you get a bevy of (often agenda driven) traders with a sprinkling of 'open minded' gamblers who cop it from both sides. [Nature of the beast.]Speccy's are a tough game.
Info gleaned from posts from
@bavarian1975 on a couple of other forums shows that of the 131 listed Biotech companies only 13 have shown an SP appreciation of 10% or more over the past year - only one has more then doubled, being the stand out leader at 350%. Around half of the 131 are down 50% or more - ADO is included and is down 75%.
Many of these companies have been around for a long long time, yet year upon year the cheer leaders continue to spruik them and the sad sacks bag them. Will ADO be a stand out again? - 2021 was looking pretty good mid way through last year. One thing for certain - the stats don't lie, so if it is, it will be one of the very few among many. If it was a horse race you would be wanting generous odds.
(20min delay)